Nadim Kanj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nadim Kanj has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Amjad Kanj
Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota
3 shared publications Ayman O. Soubani
Wayne State University, Division of Pulmonary Critical Care and Sleep Medicine, USA
2 shared publicationsGladys Honein
2 shared publicationsHussam Tabaja
Wayne State University, Department of Internal Medicine, USA
2 shared publicationsIbrahim Bawab
Department of Otolaryngology, Head and Neck surgery, American University of Beirut Medical Center, Beirut, Lebanon
2 shared publicationsJad A. Degheili
2 shared publications
Latest Publications
- Open Access
- 8 September 2023
- Published by Springer Nature in Allergy, Asthma & Clinical Immunology
- Vol. 19 (1) , 1-9
PRevalence of the Eosinophilic Phenotype Among SeveRE asthma patients in Lebanon: results of the PREPARE study
Background: The prevalence of eosinophilic asthma in Lebanon, one of the most severe phenotypes among severe asthma, is not known. This study aimed at determining the prevalence of the eosinophilic phenotype defined as an eosinophil count ≥ 300 cells/mm3 among severe asthma patients in Lebanon. Methods: The Lebanese Chapter of the PREPARE study was a national, multicenter, cross-sectional observational study. Patients aged ≥ 12 years with severe asthma were identified and prospectively enrolled during clinic visits and completed the Global Initiative for Asthma (GINA) assessment of asthma control questionnaire. Patients’ health characteristics were collected from medical records and blood samples were obtained for measurement of serum IgE levels and blood eosinophils count. Results: Overall, 101 patients (with mean age of 46.3 ± 17.0 years and 73.27% females) with severe asthma were included and, among them, 37% had eosinophilic phenotype, 67.3% had atopic phenotype with IgE > 100 IU/mL and 25.7% patients had overlapping atopic and eosinophilic phenotypes. Close to 80% had late-onset asthma, beyond 12 years of age, and around 85% had at least one severe exacerbation in the 12 months prior to study enrolment. The majority of participants [64.4%] had uncontrolled asthma, 24.7% had partially controlled symptoms and 10.9% had controlled symptoms. 19.8% of participants were on chronic oral corticosteroids, 78.2% had short course treatment of corticosteroids and all were prescribed a combination of inhaled corticosteroids and long-acting beta-agonist. Conclusions: The majority of patients with severe asthma were uncontrolled of which 37% present with an eosinophilic phenotype, which should be taken into consideration for better management of these patients in view of the novel phenotype-specific therapeutic options.
- 8 September 2023
- Published by Springer Nature in Allergy, Asthma & Clinical Immunology
- Vol. 19 (1) , 1-9
Open AccessPRevalence of the Eosinophilic Phenotype Among SeveRE asthma patients in Lebanon: results of the PREPARE study
Background: The prevalence of eosinophilic asthma in Lebanon, one of the most severe phenotypes among severe asthma, is not known. This study aimed at determining the prevalence of the eosinophilic phenotype defined as an eosinophil count ≥ 300 cells/mm3 among severe asthma patients in Lebanon. Methods: The Lebanese Chapter of the PREPARE study was a national, multicenter, cross-sectional observational study. Patients aged ≥ 12 years with severe asthma were identified and prospectively enrolled during clinic visits and completed the Global Initiative for Asthma (GINA) assessment of asthma control questionnaire. Patients’ health characteristics were collected from medical records and blood samples were obtained for measurement of serum IgE levels and blood eosinophils count. Results: Overall, 101 patients (with mean age of 46.3 ± 17.0 years and 73.27% females) with severe asthma were included and, among them, 37% had eosinophilic phenotype, 67.3% had atopic phenotype with IgE > 100 IU/mL and 25.7% patients had overlapping atopic and eosinophilic phenotypes. Close to 80% had late-onset asthma, beyond 12 years of age, and around 85% had at least one severe exacerbation in the 12 months prior to study enrolment. The majority of participants [64.4%] had uncontrolled asthma, 24.7% had partially controlled symptoms and 10.9% had controlled symptoms. 19.8% of participants were on chronic oral corticosteroids, 78.2% had short course treatment of corticosteroids and all were prescribed a combination of inhaled corticosteroids and long-acting beta-agonist. Conclusions: The majority of patients with severe asthma were uncontrolled of which 37% present with an eosinophilic phenotype, which should be taken into consideration for better management of these patients in view of the novel phenotype-specific therapeutic options.
- Open Access
- 1 October 2021
- Published by Medknow in Medical Journal of Babylon
- Vol. 18 (4) , 377-386
Evaluation and Challenges of a Smoking Cessation Program in the Eastern Mediterranean Region
Introduction: Given the lack of studies on tobacco cessation interventions in the Eastern Mediterranean region, this paper presents findings from a smoking cessation program (SCP) in a tertiary referral center. The aim is to evaluate the predictors, facilitators, and barriers associated with successful smoking cessation from both participant and provider perspectives. Materials and Methods: A mixed-method approach was used. Part 1 was a retrospective cross-sectional quantitative study with a telephone-based survey conducted on a sample of 47 patients enrolled in the SCP between March 2014 and August 2017. Part 2 was a qualitative study comprising a focus group discussion among five practitioners from the SCP. Results: Only 37% reported being adherent to the prescribed treatment and 74.5% reported receiving behavioral counseling. In the multivariate logistic regression analysis, adhering to pharmacotherapy increased the odds of being a quitter at 1 and 6 months after quit date (QD), whereas completing behavioral counseling increased the odds of being a quitter at 1, 6, and 12 months after QD. Point prevalence abstinence at 1 month and prolonged abstinence at 6 and 12 months after QD were 42.2%, 32.6%, and 24.4%, respectively. The overall relapse rate reached 62.5%. Facilitators and barriers fell under three subthemes: (1) participant factors; (2) provider factors; and (3) system factors. The most common barriers for non-compliance to the program were stress factors, nicotine addiction, accessibility and availability of pharmacotherapy, cost of the program and medications, and time restrictions. Conclusion: Adherence to pharmacotherapy and receiving behavioral counseling increase the odds of smoking abstinence maintenance. Success or failed cessation is influenced by several underlying factors operating on multiple levels and understanding them might help improve tobacco cessation interventions.
- 1 October 2021
- Published by Medknow in Medical Journal of Babylon
- Vol. 18 (4) , 377-386
Open AccessEvaluation and Challenges of a Smoking Cessation Program in the Eastern Mediterranean Region
Introduction: Given the lack of studies on tobacco cessation interventions in the Eastern Mediterranean region, this paper presents findings from a smoking cessation program (SCP) in a tertiary referral center. The aim is to evaluate the predictors, facilitators, and barriers associated with successful smoking cessation from both participant and provider perspectives. Materials and Methods: A mixed-method approach was used. Part 1 was a retrospective cross-sectional quantitative study with a telephone-based survey conducted on a sample of 47 patients enrolled in the SCP between March 2014 and August 2017. Part 2 was a qualitative study comprising a focus group discussion among five practitioners from the SCP. Results: Only 37% reported being adherent to the prescribed treatment and 74.5% reported receiving behavioral counseling. In the multivariate logistic regression analysis, adhering to pharmacotherapy increased the odds of being a quitter at 1 and 6 months after quit date (QD), whereas completing behavioral counseling increased the odds of being a quitter at 1, 6, and 12 months after QD. Point prevalence abstinence at 1 month and prolonged abstinence at 6 and 12 months after QD were 42.2%, 32.6%, and 24.4%, respectively. The overall relapse rate reached 62.5%. Facilitators and barriers fell under three subthemes: (1) participant factors; (2) provider factors; and (3) system factors. The most common barriers for non-compliance to the program were stress factors, nicotine addiction, accessibility and availability of pharmacotherapy, cost of the program and medications, and time restrictions. Conclusion: Adherence to pharmacotherapy and receiving behavioral counseling increase the odds of smoking abstinence maintenance. Success or failed cessation is influenced by several underlying factors operating on multiple levels and understanding them might help improve tobacco cessation interventions.
- Open Access
- 1 October 2021
- Published by Medknow in Medical Journal of Babylon
- Vol. 18 (4) , 327-332
The Experience of a Middle Eastern Smoking Cessation Program
Introduction: Almost one-third of the Lebanese population are active smokers, with limited knowledge about their attitudes toward existing smoking cessation interventions. This study aims at exploring the facilitators and barriers facing a smoking cessation program (SCP) in a Lebanese tertiary referral center from the providers’ perspective. Materials and Methods: This is a qualitative study comprising a focus group discussion (FGD) among five practitioners from the SCP. The data collected were then transcribed and summarized by coding, simplifying, and transforming the raw data into major themes and subthemes as per the Miles and Huberman method of organization. Results: Facilitators and barriers fell under three subthemes: (1) participant factors, (2) provider factors, and (3) system factors. Facilitators included motivation and concerns about health among patients, in addition to increased behavioral support from providers. Meanwhile, barriers were much predominant and included stress factors and nicotine addiction among patients, time constraints among providers, lack of an effective referral system, inaccessibility, and unavailability of pharmacotherapy as well as a pro-smoking environment with weakly enforced tobacco legislation. Conclusion: Our findings implicate the need for multilevel strategies to help improve smoking cessation interventions. Addressing identified barriers is of paramount importance to help develop effective, accessible, and culturally specific tobacco treatment.
- 1 October 2021
- Published by Medknow in Medical Journal of Babylon
- Vol. 18 (4) , 327-332
Open AccessThe Experience of a Middle Eastern Smoking Cessation Program
Introduction: Almost one-third of the Lebanese population are active smokers, with limited knowledge about their attitudes toward existing smoking cessation interventions. This study aims at exploring the facilitators and barriers facing a smoking cessation program (SCP) in a Lebanese tertiary referral center from the providers’ perspective. Materials and Methods: This is a qualitative study comprising a focus group discussion (FGD) among five practitioners from the SCP. The data collected were then transcribed and summarized by coding, simplifying, and transforming the raw data into major themes and subthemes as per the Miles and Huberman method of organization. Results: Facilitators and barriers fell under three subthemes: (1) participant factors, (2) provider factors, and (3) system factors. Facilitators included motivation and concerns about health among patients, in addition to increased behavioral support from providers. Meanwhile, barriers were much predominant and included stress factors and nicotine addiction among patients, time constraints among providers, lack of an effective referral system, inaccessibility, and unavailability of pharmacotherapy as well as a pro-smoking environment with weakly enforced tobacco legislation. Conclusion: Our findings implicate the need for multilevel strategies to help improve smoking cessation interventions. Addressing identified barriers is of paramount importance to help develop effective, accessible, and culturally specific tobacco treatment.
- Open Access
- 23 August 2018
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 25, 184-186
Migrating gossypiboma mimicking aspergilloma twenty years after mediastinal surgery
- 23 August 2018
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 25, 184-186
Open AccessMigrating gossypiboma mimicking aspergilloma twenty years after mediastinal surgery
- Open Access
- 11 July 2018
- Published by Wiley in Case Reports in Pulmonology
- Vol. 2018, 1-3
Traumatic Pulmonary Pseudocyst Mimicking a Congenital Cystic Lung Disease
Traumatic pulmonary pseudocyst (TPP) is a rare entity that occurs following a trauma to the chest. It usually presents as multiple cystic lesions on thoracic imaging. It is treated conservatively and tends to completely resolve after few months. In the absence of striking signs of trauma such as rib fractures, TPP can be mistaken for other cystic lung diseases. We present a case of TPP in a 17-year-old male who was seen for mild hemoptysis after falling off a cliff. The extent of his right lower lobe cystic lesions along with the lack of major signs of trauma led to an incorrect diagnosis of congenital pulmonary airway malformation. The patient was considered for lobectomy, which he refused. Imaging of the chest repeated one and three years later showed complete resolution of the lesions.
- 11 July 2018
- Published by Wiley in Case Reports in Pulmonology
- Vol. 2018, 1-3
Open AccessTraumatic Pulmonary Pseudocyst Mimicking a Congenital Cystic Lung Disease
Traumatic pulmonary pseudocyst (TPP) is a rare entity that occurs following a trauma to the chest. It usually presents as multiple cystic lesions on thoracic imaging. It is treated conservatively and tends to completely resolve after few months. In the absence of striking signs of trauma such as rib fractures, TPP can be mistaken for other cystic lung diseases. We present a case of TPP in a 17-year-old male who was seen for mild hemoptysis after falling off a cliff. The extent of his right lower lobe cystic lesions along with the lack of major signs of trauma led to an incorrect diagnosis of congenital pulmonary airway malformation. The patient was considered for lobectomy, which he refused. Imaging of the chest repeated one and three years later showed complete resolution of the lesions.
- 1 April 2018
- Published by Wolters Kluwer Health in Journal of Bronchology & Interventional Pulmonology
- Vol. 25 (2) , 141-143
A Burned-out Testicular Tumor
- 1 April 2018
- Published by Wolters Kluwer Health in Journal of Bronchology & Interventional Pulmonology
- Vol. 25 (2) , 141-143
A Burned-out Testicular Tumor
- 18 December 2016
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 69 (1) , 42-46
Phonatory Symptoms and Acoustic Findings in Patients with Asthma: A Cross-Sectional Controlled Study
To investigate the prevalence of phonatory symptoms, perceptual, acoustic and aerodynamic findings in patients with asthma compared to a control group. This study is a cross-sectional study. A total of 50 subjects, 31 asthmatic and 19 control subjects matched according to age and gender were enrolled in this study. All subjects were asked about the presence or absence of dysphonia, vocal fatigue, phonatory effort, cough, dyspnea, and respiratory failure. Perceptual evaluation, acoustic analysis and aerodynamic measurements were also performed. Patient’s self assessment using the Voice Handicap Index 10 was reported. The mean age of patients was 43.5 years with a female to male ratio of 2:1. There was a statistically significant difference in the prevalence of dysphonia between the two groups (32.3 vs. 5.3%, p value 0.025) with a non-significant higher prevalence of vocal fatigue and phonatory effort. The overall grade of dysphonia was significantly higher in asthmatics compared to controls (p value 0.002). Patients with asthma had also significantly higher degree of asthenia and straining (p value of 0.04 and 0.008, respectively) with borderline significant difference with respect to roughness. There was no significant difference in the means of any of the acoustic parameters between patients and controls except for Shimmer, which was higher in the asthmatic group (p value of 0.037). There was also no significant difference in the Maximum phonation time between the two groups. Dysphonia is significantly more prevalent in patients with asthma compared to controls.
- 18 December 2016
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 69 (1) , 42-46
Phonatory Symptoms and Acoustic Findings in Patients with Asthma: A Cross-Sectional Controlled Study
To investigate the prevalence of phonatory symptoms, perceptual, acoustic and aerodynamic findings in patients with asthma compared to a control group. This study is a cross-sectional study. A total of 50 subjects, 31 asthmatic and 19 control subjects matched according to age and gender were enrolled in this study. All subjects were asked about the presence or absence of dysphonia, vocal fatigue, phonatory effort, cough, dyspnea, and respiratory failure. Perceptual evaluation, acoustic analysis and aerodynamic measurements were also performed. Patient’s self assessment using the Voice Handicap Index 10 was reported. The mean age of patients was 43.5 years with a female to male ratio of 2:1. There was a statistically significant difference in the prevalence of dysphonia between the two groups (32.3 vs. 5.3%, p value 0.025) with a non-significant higher prevalence of vocal fatigue and phonatory effort. The overall grade of dysphonia was significantly higher in asthmatics compared to controls (p value 0.002). Patients with asthma had also significantly higher degree of asthenia and straining (p value of 0.04 and 0.008, respectively) with borderline significant difference with respect to roughness. There was no significant difference in the means of any of the acoustic parameters between patients and controls except for Shimmer, which was higher in the asthmatic group (p value of 0.037). There was also no significant difference in the Maximum phonation time between the two groups. Dysphonia is significantly more prevalent in patients with asthma compared to controls.
- Open Access
- 11 August 2015
- Published by Hindawi Limited in Case Reports in Medicine
- Vol. 2015, 1-4
Pulmonary Embolism in a Sarcoidosis Patient Double Heterozygous for Methylenetetrahydrofolate Reductase Gene Polymorphisms and Factor V Leiden and Homozygous for the D-Allele of Angiotensin Converting Enzyme Gene
Sarcoidosis is a multisystem granulomatous disease of unknown etiology and pathogenesis. It presents in patients younger than 40 years of age. The lungs are the most commonly affected organ. Till the present day, there is no single specific test that will accurately diagnose sarcoidosis; as a result, the diagnosis of sarcoidosis relies on a combination of clinical, radiologic, and histologic findings. Patients with sarcoidosis have been found to have an increased risk of pulmonary embolism compared to the normal population. MTHFR and factor V Leiden mutations have been reported to increase the risk of thrombosis in patients. We hereby present a case of a middle aged man with sarcoidosis who developed a right main pulmonary embolism and was found to be double heterozygous for methylenetetrahydrofolate reductase gene polymorphisms and factor V Leiden and homozygous for the D-allele of the angiotensin converting enzyme gene. Sarcoidosis is a multisystem granulomatous disease of unknown etiology and pathogenesis. It presents in patients younger than 40 years of age. The lungs are the most commonly affected organ. Till the present day, there is no single specific test that will accurately diagnose sarcoidosis; as a result, the diagnosis of sarcoidosis relies on a combination of clinical, radiologic, and histologic findings. Patients with sarcoidosis have been found to have an increased risk of pulmonary embolism compared to the normal population. MTHFR and factor V Leiden mutations have been reported to increase the risk of thrombosis in patients. We hereby present a case of a middle aged man with sarcoidosis who developed a right main pulmonary embolism and was found to be double heterozygous for methylenetetrahydrofolate reductase gene polymorphisms and factor V Leiden and homozygous for the D-allele of the angiotensin converting enzyme gene.
- 11 August 2015
- Published by Hindawi Limited in Case Reports in Medicine
- Vol. 2015, 1-4
Open AccessPulmonary Embolism in a Sarcoidosis Patient Double Heterozygous for Methylenetetrahydrofolate Reductase Gene Polymorphisms and Factor V Leiden and Homozygous for the D-Allele of Angiotensin Converting Enzyme Gene
Sarcoidosis is a multisystem granulomatous disease of unknown etiology and pathogenesis. It presents in patients younger than 40 years of age. The lungs are the most commonly affected organ. Till the present day, there is no single specific test that will accurately diagnose sarcoidosis; as a result, the diagnosis of sarcoidosis relies on a combination of clinical, radiologic, and histologic findings. Patients with sarcoidosis have been found to have an increased risk of pulmonary embolism compared to the normal population. MTHFR and factor V Leiden mutations have been reported to increase the risk of thrombosis in patients. We hereby present a case of a middle aged man with sarcoidosis who developed a right main pulmonary embolism and was found to be double heterozygous for methylenetetrahydrofolate reductase gene polymorphisms and factor V Leiden and homozygous for the D-allele of the angiotensin converting enzyme gene. Sarcoidosis is a multisystem granulomatous disease of unknown etiology and pathogenesis. It presents in patients younger than 40 years of age. The lungs are the most commonly affected organ. Till the present day, there is no single specific test that will accurately diagnose sarcoidosis; as a result, the diagnosis of sarcoidosis relies on a combination of clinical, radiologic, and histologic findings. Patients with sarcoidosis have been found to have an increased risk of pulmonary embolism compared to the normal population. MTHFR and factor V Leiden mutations have been reported to increase the risk of thrombosis in patients. We hereby present a case of a middle aged man with sarcoidosis who developed a right main pulmonary embolism and was found to be double heterozygous for methylenetetrahydrofolate reductase gene polymorphisms and factor V Leiden and homozygous for the D-allele of the angiotensin converting enzyme gene.
- 1 September 2014
- Published by Elsevier in Respiratory Medicine
- Vol. 108 (9) , 1241-1253
The growing epidemic of water pipe smoking: Health effects and future needs
- 1 September 2014
- Published by Elsevier in Respiratory Medicine
- Vol. 108 (9) , 1241-1253
The growing epidemic of water pipe smoking: Health effects and future needs